CLEAR CELL ENDOMETRIAL CARCINOMA

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting CLEAR CELL ENDOMETRIAL CARCINOMA:

# Drug Count
0 INTERFERON BETA-1A 4
1 ADALIMUMAB 3
2 ALPRAZOLAM 2
3 ASCORBIC ACID 2
4 LIRAGLUTIDE 2
5 METHOTREXATE 2
6 METHOTREXATE SODIUM 2
7 NEBIVOLOL 2
8 NEBIVOLOL HYDROCHLORIDE 2
9 RAMIPRIL 2
See all common drugs associated with CLEAR CELL ENDOMETRIAL CARCINOMA

CLEAR CELL ENDOMETRIAL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLOMIPHENE CITRATE 1 0.0007
1 MENOTROPINS 1 0.0005
2 ICOSAPENT ETHYL 1 0.0001
3 ASCORBIC ACID 2 0.0001
4 NEBIVOLOL HYDROCHLORIDE 2 0.0001
5 TIZANIDINE HYDROCHLORIDE 1 0.0001
6 LIRAGLUTIDE 2 0.0000
7 ERGOCALCIFEROL 1 0.0000
8 MODAFINIL 1 0.0000
9 INTERFERON BETA-1A 4 0.0000
See all drugs enriched for association with CLEAR CELL ENDOMETRIAL CARCINOMA